LAVAL, Quebec, October 28, 2013 - BELLUS Health Inc. , a drug development company focussed on rare diseases, today announced an agreement with AmorChem Holdings Inc. to develop drug candidates for the treatment of AL amyloidosis.
http://www.biospace.com/news_story.aspx?StoryID=319201&full=1
http://www.biospace.com/news_story.aspx?StoryID=319201&full=1
No comments:
Post a Comment